SGRY — Surgery Partners Income Statement
0.000.00%
Last trade - 00:00
- $3.12bn
- $7.07bn
- $2.74bn
- 77
- 58
- 43
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,831 | 1,860 | 2,225 | 2,539 | 2,743 |
Cost of Revenue | |||||
Gross Profit | 509 | 467 | 582 | 657 | 732 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,596 | 1,677 | 1,923 | 2,194 | 2,415 |
Operating Profit | 236 | 183 | 302 | 345 | 328 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 54.6 | -18.8 | 81.2 | 110 | 135 |
Provision for Income Taxes | |||||
Net Income After Taxes | 45.1 | 1.3 | 70.7 | 87 | 135 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -74.8 | -116 | -70.9 | -54.6 | -11.9 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -111 | -156 | -81.2 | -54.6 | -11.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -1.65 | -2.79 | -0.822 | -0.434 | 0.519 |